Ra Capital Management as of March 31, 2022
Portfolio Holdings for Ra Capital Management
Ra Capital Management holds 96 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 19.4 | $888M | 7.6M | 117.36 | |
| Biogen Idec (BIIB) | 3.3 | $153M | 727k | 210.60 | |
| Aerovate Therapeutics (AVTE) | 3.3 | $152M | 8.3M | 18.33 | |
| Cytek Biosciences (CTKB) | 3.1 | $144M | 13M | 10.78 | |
| Iteos Therapeutics (ITOS) | 3.1 | $142M | 4.4M | 32.18 | |
| Travere Therapeutics (TVTX) | 2.8 | $127M | 4.9M | 25.77 | |
| Janux Therapeutics (JANX) | 2.7 | $124M | 8.7M | 14.34 | |
| Vaxcyte (PCVX) | 2.4 | $111M | 4.6M | 24.15 | |
| Eliem Therapeutics (ELYM) | 2.4 | $110M | 13M | 8.39 | |
| ImmunoGen | 2.3 | $104M | 22M | 4.76 | |
| Dice Therapeutics | 2.2 | $100M | 5.2M | 19.13 | |
| Gh Research Ordinary Shares (GHRS) | 1.9 | $88M | 4.8M | 18.29 | |
| Forma Therapeutics Hldgs SHS | 1.8 | $84M | 9.0M | 9.30 | |
| Tyra Biosciences (TYRA) | 1.7 | $77M | 7.2M | 10.70 | |
| Point Biopharma Global | 1.6 | $72M | 9.0M | 7.97 | |
| Celldex Therapeutics Com New (CLDX) | 1.5 | $71M | 2.1M | 34.06 | |
| Bellus Health Com New | 1.5 | $70M | 10M | 6.88 | |
| Enanta Pharmaceuticals (ENTA) | 1.5 | $69M | 964k | 71.18 | |
| Vor Biopharma (VOR) | 1.5 | $67M | 11M | 6.04 | |
| Nkarta (NKTX) | 1.4 | $64M | 5.6M | 11.38 | |
| Mirati Therapeutics | 1.3 | $60M | 734k | 82.22 | |
| Day One Biopharmaceuticals I (DAWN) | 1.3 | $60M | 6.1M | 9.92 | |
| Rhythm Pharmaceuticals (RYTM) | 1.2 | $56M | 4.9M | 11.52 | |
| An2 Therapeutics (ANTX) | 1.2 | $55M | 3.7M | 15.07 | |
| Relmada Therapeutics (RLMD) | 1.2 | $54M | 2.0M | 26.99 | |
| Macrogenics (MGNX) | 1.2 | $54M | 6.1M | 8.81 | |
| Natera (NTRA) | 1.2 | $53M | 1.3M | 40.68 | |
| Instil Bio | 1.1 | $52M | 4.9M | 10.75 | |
| Novavax Com New (NVAX) | 1.1 | $51M | 693k | 73.65 | |
| Kinnate Biopharma (KNTE) | 1.0 | $48M | 4.3M | 11.26 | |
| Vera Therapeutics Cl A (VERA) | 1.0 | $46M | 2.0M | 23.49 | |
| Pardes Biosciences | 1.0 | $45M | 6.2M | 7.22 | |
| Icosavax | 0.9 | $42M | 6.0M | 7.04 | |
| Tenaya Therapeutics (TNYA) | 0.9 | $42M | 3.6M | 11.78 | |
| Geron Corporation (GERN) | 0.9 | $41M | 30M | 1.36 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.9 | $41M | 3.4M | 12.15 | |
| Avidity Biosciences Ord (RNA) | 0.9 | $40M | 2.2M | 18.47 | |
| Acumen Pharmaceuticals (ABOS) | 0.8 | $38M | 9.8M | 3.91 | |
| Rxsight (RXST) | 0.8 | $38M | 3.1M | 12.38 | |
| Pmv Pharmaceuticals (PMVP) | 0.8 | $36M | 1.7M | 20.82 | |
| Design Therapeutics (DSGN) | 0.8 | $35M | 2.2M | 16.15 | |
| Rocket Pharmaceuticals (RCKT) | 0.7 | $33M | 2.1M | 15.86 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.7 | $32M | 3.6M | 8.97 | |
| Guardant Health (GH) | 0.7 | $32M | 476k | 66.24 | |
| Aclaris Therapeutics (ACRS) | 0.7 | $31M | 1.8M | 17.24 | |
| Chemocentryx | 0.6 | $29M | 1.2M | 25.07 | |
| Kalvista Pharmaceuticals (KALV) | 0.6 | $29M | 1.9M | 14.74 | |
| Lianbio Sponsored Ads (LIANY) | 0.6 | $28M | 7.7M | 3.71 | |
| Dyne Therapeutics (DYN) | 0.6 | $27M | 2.8M | 9.64 | |
| Verona Pharma Sponsored Ads (VRNA) | 0.6 | $25M | 5.1M | 4.99 | |
| Edgewise Therapeutics (EWTX) | 0.6 | $25M | 2.6M | 9.70 | |
| Satsuma Pharmaceuticals Ord | 0.5 | $23M | 5.9M | 3.80 | |
| Connect Biopharma Hldgs Ads (CNTB) | 0.5 | $21M | 7.0M | 3.02 | |
| Werewolf Therapeutics (HOWL) | 0.4 | $19M | 4.3M | 4.40 | |
| 89bio (ETNB) | 0.4 | $19M | 5.0M | 3.77 | |
| Tango Therapeutics (TNGX) | 0.4 | $17M | 2.3M | 7.58 | |
| Relay Therapeutics (RLAY) | 0.4 | $16M | 549k | 29.93 | |
| Chinook Therapeutics | 0.4 | $16M | 1.0M | 16.36 | |
| Synlogic | 0.3 | $16M | 6.7M | 2.40 | |
| Wave Life Sciences SHS (WVE) | 0.3 | $16M | 7.8M | 2.00 | |
| Scpharmaceuticals (SCPH) | 0.3 | $15M | 2.7M | 5.68 | |
| Kala Pharmaceuticals | 0.3 | $15M | 11M | 1.38 | |
| Solid Biosciences | 0.3 | $15M | 12M | 1.20 | |
| Achilles Therapeutics Sponsored Ads (ACHL) | 0.3 | $15M | 5.0M | 2.94 | |
| Da32 Life Scnce Tec Acqstn C Class A Com | 0.3 | $15M | 1.5M | 9.72 | |
| Milestone Pharmaceuticals (MIST) | 0.3 | $14M | 2.2M | 6.42 | |
| Xilio Therapeutics (XLO) | 0.3 | $14M | 2.0M | 7.07 | |
| Graphite Bio | 0.3 | $14M | 2.7M | 5.10 | |
| Otonomy | 0.3 | $13M | 5.6M | 2.40 | |
| Cyteir Therapeutics | 0.3 | $13M | 3.4M | 3.77 | |
| Bcls Acquisition Corp Com Cl A | 0.3 | $12M | 1.3M | 9.87 | |
| Century Therapeutics (IPSC) | 0.3 | $12M | 914k | 12.59 | |
| Morphic Hldg (MORF) | 0.2 | $11M | 279k | 40.15 | |
| Akouos | 0.2 | $11M | 2.3M | 4.75 | |
| Concert Pharmaceuticals I equity | 0.2 | $10M | 3.0M | 3.37 | |
| Frazier Lifesciences Acqu Cl A Shs | 0.2 | $10M | 1.0M | 9.99 | |
| Io Biotech (IOBT) | 0.2 | $9.8M | 1.9M | 5.30 | |
| Allovir (ALVR) | 0.2 | $9.7M | 1.4M | 6.75 | |
| Arya Sciences Acquisitn Class A Ord Shs | 0.2 | $9.7M | 1.0M | 9.71 | |
| Pyxis Oncology (PYXS) | 0.2 | $9.2M | 2.3M | 4.04 | |
| Astria Therapeutics (ATXS) | 0.2 | $8.5M | 1.3M | 6.71 | |
| 5 01 Acquisition Corp Com Cl A | 0.2 | $7.4M | 750k | 9.85 | |
| Black Diamond Therapeutics (BDTX) | 0.2 | $7.2M | 2.6M | 2.77 | |
| Verve Therapeutics (VERV) | 0.2 | $7.1M | 310k | 22.82 | |
| Orchard Therapeutics Ads | 0.2 | $6.9M | 9.7M | 0.71 | |
| Entera Bio SHS (ENTX) | 0.1 | $6.8M | 2.4M | 2.87 | |
| Health Sciences Acq Corp 2 Ord Shs | 0.1 | $6.2M | 625k | 9.91 | |
| Larimar Therapeutics (LRMR) | 0.1 | $5.2M | 1.3M | 4.05 | |
| Cue Health (HLTH) | 0.1 | $4.8M | 750k | 6.45 | |
| Phasebio Pharmaceuticals (PHASQ) | 0.1 | $3.8M | 2.9M | 1.32 | |
| Cullinan Oncology (CGEM) | 0.1 | $3.7M | 350k | 10.47 | |
| Tscan Therapeutics (TCRX) | 0.1 | $2.9M | 1.0M | 2.80 | |
| Biomea Fusion (BMEA) | 0.0 | $2.2M | 500k | 4.46 | |
| Olema Pharmaceuticals (OLMA) | 0.0 | $2.1M | 505k | 4.26 | |
| CVRX (CVRX) | 0.0 | $1.6M | 275k | 5.99 | |
| Compass Therapeutics (CMPX) | 0.0 | $730k | 533k | 1.37 |
